a

FDA Sends Warning Letter to Lucero Medical on Spinal Fusion Device

Written by  Laura Miller | April 05, 2012
Social sharing
The Food and Drug Administration has issued Lucero Medical a letter of warning related to its spinal fusion device Enduramesh.
The letter warned the company about documentation and quality control issues related to Enduramesh, naming eight violations at its Hinckley, Ohio, facility. The FDA also issued a recall of the device in February.

The Enduramesh product cited is different from the Enduramesh Model 762.XXX, which was cleared by the FDA in April 2010.

More Articles on Spinal Devices:

15 New Spine Devices & Systems to Know

Expanding Orthopedics Receives Patent for Spine Device

Medtronic Pays $85M Settlement in Infuse Lawsuit


© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.

blog comments powered by Disqus